Dauntless Investment Group, LLC Gain Therapeutics, Inc. Transaction History
Dauntless Investment Group, LLC
- $85.4 Billion
- Q1 2025
A detailed history of Dauntless Investment Group, LLC transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Dauntless Investment Group, LLC holds 125,584 shares of GANX stock, worth $270,005. This represents 0.28% of its overall portfolio holdings.
Number of Shares
125,584Holding current value
$270,005% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding GANX
# of Institutions
32Shares Held
2.91MCall Options Held
5.7KPut Options Held
10.6K-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$1.27 Million0.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$1.22 Million0.06% of portfolio
-
Geode Capital Management, LLC Boston, MA267KShares$574,9550.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA255KShares$548,2280.0% of portfolio
-
Joel Greenblatt Gotham Asset Management, LLC | New York, Ny158KShares$340,0330.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $25.5M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...